Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis.

about

Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis.

Item

http://www.wikidata.org/entity/Q50129104

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Profile of dupilumab and its p ...... e-to-severe atopic dermatitis.

@en

Profile of dupilumab and its p ...... e-to-severe atopic dermatitis.

@nl

type

Item

label

Profile of dupilumab and its p ...... e-to-severe atopic dermatitis.

@en

Profile of dupilumab and its p ...... e-to-severe atopic dermatitis.

@nl

prefLabel

Profile of dupilumab and its p ...... e-to-severe atopic dermatitis.

@en

Profile of dupilumab and its p ...... e-to-severe atopic dermatitis.

@nl

P1476

Profile of dupilumab and its p ...... te-to-severe atopic dermatitis

@en

P2093

Alison Ehrlich

http://www.w3.org/2001/XMLSchema#string

Lori Kim

http://www.w3.org/2001/XMLSchema#string

Momina Mazhar

http://www.w3.org/2001/XMLSchema#string

Olabola Awosika

http://www.w3.org/2001/XMLSchema#string

P2860

New insights into T cells and their signature cytokines in atopic dermatitis

The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis

Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.

Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health

IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation.

Changes of antimicrobial peptides and transepidermal water loss after topical application of tacrolimus and ceramide-dominant emollient in patients with atopic dermatitis.

Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies

Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.

Persistence of mild to moderate atopic dermatitis.

P304

41-49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CCID.S123329

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Monica Rengifo-Pardo

P577

2018-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29416367

http://www.w3.org/2001/XMLSchema#string

P932

5789047

http://www.w3.org/2001/XMLSchema#string